Electrohydrodynamic atomization of drug solutions for inhalation purposes

P. Zanen, K. Geerse, J. C. M. Marijnissen, J. W. J. Lammers (Utrecht, Delft, The Netherlands)

Source: Annual Congress 2001 - New developments in inhaler delivery systems
Session: New developments in inhaler delivery systems
Session type: Thematic Poster Session
Number: 699
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Zanen, K. Geerse, J. C. M. Marijnissen, J. W. J. Lammers (Utrecht, Delft, The Netherlands). Electrohydrodynamic atomization of drug solutions for inhalation purposes. Eur Respir J 2001; 16: Suppl. 31, 699

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Reduction in nebulisation time of aqueous drug solutions by the eFlow rapid in comparison to a jet nebuliser to improve patient convenience and compliance
Source: Eur Respir J 2005; 26: Suppl. 49, 338s
Year: 2005

Aerosol performance of two ambroxol inhalation products upon nebulisation by the eFlow rapid
Source: Eur Respir J 2006; 28: Suppl. 50, 212s
Year: 2006

Toxic gas inhalation during the use of house cleaning materials
Source: Eur Respir J 2006; 28: Suppl. 50, 699s
Year: 2006

A preliminary assessment of the stability of 5-CF containing liposomes following aerosolisation with TouchSprayÔ technology and a commercial jet nebuliser
Source: Eur Respir J 2003; 22: Suppl. 45, 471s
Year: 2003

Aerosolization of nanoparticle suspensions in ethanol using Mystic™ drug delivery technology
Source: Eur Respir J 2002; 20: Suppl. 38, 541s
Year: 2002

The generation of monodisperse pharmacological aerosols using a spinning-top aerosol generator (STAG)
Source: Eur Respir J 2005; 26: Suppl. 49, 125s
Year: 2005

Consider the turbulent energy not inhalation flow when patients use dry powder inhalers (DPIs)
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012


Validation of monodisperse corticosteroid aerosols for in-vivo delivery
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008


A novel submicron budesonide suspension demonstrates equivalent nebulization times compared to cyclodextrin-based solution formulations
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Particle size and gravimetric characteristics of Clenny Aerosol, a new jet nebulizer with breath enhanced bulb
Source: Eur Respir J 2001; 18: Suppl. 33, 99s
Year: 2001

Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Inhalation parameters from an integrated electronic multidose dry powder inhaler (eMDPI)
Source: International Congress 2018 – Asthma: clinical screening tools
Year: 2018

Oxygen prescription, monitoring and use as a nebuliser driving gas
Source: Eur Respir J 2006; 28: Suppl. 50, 53s
Year: 2006

Effect of device and formulation on delivery of budesonide suspensions by nebulizers
Source: Eur Respir J 2002; 20: Suppl. 38, 542s
Year: 2002

Aerosol delivery characteristics from a new jet nebulizer in comparison with commercially available jet nebulizers
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Inhaled therapies: plastics, propellants, and pollutants
Source: Virtual Congress 2021 – Environment, air pollution, health and respiratory disease
Year: 2021


Slow particle dissolution may limit lung absorption of inhaled pharmaceuticals in the lungs
Source: Eur Respir J 2006; 28: Suppl. 50, 210s
Year: 2006

Reduction of nebulization time can be achieved with a new jet nebulizer design
Source: Eur Respir J 2006; 28: Suppl. 50, 211s
Year: 2006

A breath-actuated nebulizer provides greatly reduced fugitive aerosol emissions compared with a continuously operating nebulizer
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II
Year: 2007


Delivery efficiency of electronic and jet nebulisers aerosolising a colistimethate sodium solution
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009